Avalo Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
25.03.25
/
50%
€0.041
Target price
25.03.26
€21.28
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.03.26. The prediction end date can be changed by Jefferies_Financial_ at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avalo Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.754% | -1.027% |
| iShares Nasdaq 100 | -2.859% | -4.266% |
| iShares Nikkei 225® | 4.946% | 5.736% |
| iShares S&P 500 | -1.254% | -2.357% |
Comments by Jefferies_Financial_ for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat